Atorvastatin Calcium
Product Images NDC 70934-091

5 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70934-091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

70934 091 90 Rev A 12 18

70934 091 90 Rev A 12 18
Label for Atorvastatin Calcium Tablets, 40 mg, containing 90 tablets. The label states it is for prescription use only (Rx Only) and includes storage instructions, manufacturer information (Denton Pharma, Inc. DBA Northwind Pharmaceuticals), and the product NDC 70934-091-90. It also shows several repetitions of the product name, quantity, NDC, lot number, manufacturing, and expiration dates in different label sections.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line chart showing cumulative incidence (%) over time in years, comparing Atorvastatin and Placebo groups. The solid line represents Atorvastatin with lower cumulative incidence than the dashed Placebo line, with a hazard ratio (HR) of 0.64 (0.50-0.83) and p=0.0005 indicated on the graph.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph comparing cumulative hazard percentage over time for Atorvastatin versus placebo. The x-axis represents time to first primary endpoint over four years of follow-up, and the y-axis shows cumulative hazard percentage. Two curves compare Atorvastatin (solid line) with placebo (dotted line). A hazard ratio of 0.63 with confidence interval and p-value is noted on the chart.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing the percentage of subjects experiencing a cardiovascular event over five years between Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line). The x-axis shows time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. A hazard ratio of 0.78 (0.69-0.89) and P-value of 0.0002 are indicated.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium, showing two calcium ions and the atorvastatin molecule with its phenyl groups and functional groups clearly depicted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.